Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

NCT06537908 ·Status: RECRUITING

The Efficacy of Sequential RT After Triple Therapy for uHCC

NCT07052448 ·Status: ENROLLING_BY_INVITATION

Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant

NCT03966209 ·Status: UNKNOWN ·Phase: PHASE1

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

NCT04627012 ·Status: COMPLETED

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

NCT06708650 ·Status: NOT_YET_RECRUITING ·Phase: NA

PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

NCT07053072 ·Status: RECRUITING ·Phase: PHASE1

Targeted Internal Radiation Therapy in Advanced HCC Patients.

NCT02724267 ·Status: COMPLETED ·Phase: NA

Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

NCT06530784 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma

NCT05411926 ·Status: UNKNOWN

Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma

NCT06966986 ·Status: ACTIVE_NOT_RECRUITING

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

NCT07100405 ·Status: RECRUITING

Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma

NCT01328223 ·Status: UNKNOWN

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

NCT06423144 ·Status: NOT_YET_RECRUITING

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

NCT07157969 ·Status: RECRUITING ·Phase: PHASE2

Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies

NCT05803928 ·Status: RECRUITING ·Phase: PHASE1

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

NCT04163237 ·Status: UNKNOWN ·Phase: PHASE3

Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma

NCT06034977 ·Status: RECRUITING ·Phase: PHASE2

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

NCT06248554 ·Status: RECRUITING ·Phase: NA

Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy

NCT05057104 ·Status: UNKNOWN

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients

NCT06583993 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

NCT04393220 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

NCT06040177 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

NCT06746194 ·Status: RECRUITING

A Study to Evaluate SHR-1210 in Subjects With Advanced HCC

NCT02989922 ·Status: COMPLETED ·Phase: PHASE2

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

NCT02557503 ·Status: UNKNOWN ·Phase: PHASE4